Contact UsInvestorsCareersMediaScienceContact Us
HomeNewsNews & Featured StoriesBreakthrough Nation II11/11/2022Breakthrough Nation II: A bold agenda for changeThe pandemic has demonstrated how critical the life sciences industry is to the nation’s health, wealth and resilience, but long-term success requires strong public–private partnership.

'Breakthrough Nation II' provides our latest thinking for how industry and government can work better together, setting out a bold 10-point agenda for change. Informed by our 70 years in the UK and our unique experiences throughout the pandemic, our recommendations seek to build upon the ambitions set out in the Life Sciences Vision.

These bold ambitions must now be matched by bold actions. To support the UK Government and the NHS to achieve its goals, we believe the 10-points below need to be embraced and advanced in the years ahead:

Apply the COVID-19 ‘mission-led’ ethos to address other major healthcare challenges


The ‘mission-led’ approach of the Vaccine Taskforce must now be applied to address other major healthcare challenges

Prevention Revolution
Deliver a prevention revolution to prepare the nation against future health threats


Establish a commission bringing Government, business and civil society together to examine the relationship between the ‘health and wealth’ of the nation and make recommendations for a post-pandemic economy


Develop a new strategy for UK vaccination which maximises protection across all age groups and realises the true value that vaccines offer to British society


Continue to prioritise efforts to tackle the major public health challenge of antimicrobial resistance

No Patient Left Behind
Ensure that no patient in need is left behind, no matter how rare their condition


Realise the Brexit opportunity for patients by matching the goal of rapid regulatory approval for new medicines with rapid patient access


Deliver a step forward for rare disease patients who continue to face challenges accessing treatments in the UK


Achieve consistent and widespread adoption of cost-effective innovative medicines across the NHS

Global Investment Magnet
Set the UK apart as a destination for global investment in life sciences


Create a digitally enabled and pro-innovation clinical research environment which leads to increased investment in UK clinical trials


Take targeted action to improve investment in life sciences R&D and manufacturing whilst continuing to support global free trade and open supply chains

Net Zero Champion
Unite with the life sciences industry to deliver a net zero NHS


Establish a cross-sector Net Zero taskforce, bringing together NHS and cross-industry partners to determine technological, economic and regulatory reforms needed to meet shared Net Zero targets.

Breakthrough Nation II

A 10-point plan for how life sciences can drive the UK's health, wealth and resilience beyond the pandemic.

Published September 2022.

Download the full report
PP-UNP-GBR-3303 / January 2023
Science Products Responsibility PartnershipsCareers Privacy Statement Terms of Use Contact UsSitemap Copyright © 2017-2024 Pfizer Limited. PP-UNP-GBR-8108 / January 2024. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427. This website is intended for the general public in the UK.